Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

Literature DB >> 16705023

Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

Gerd Walz.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16705023 DOI： 10.1093/ndt/gfl246

Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors: Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal: World J Gastroenterol Date: 2013-09-21 Impact factor: 5.742

2. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

Authors: Imed Helal; Berenice Reed; Kim McFann; Xiang-Dong Yan; Godela M Fick-Brosnahan; Melissa Cadnapaphornchai; Robert W Schrier
Journal: Clin J Am Soc Nephrol Date: 2011-09-08 Impact factor: 8.237

3. Volumetric analysis of MRI data monitoring the treatment of polycystic kidney disease in a mouse model.

Authors: Stathis Hadjidemetriou; Wilfried Reichardt; Juergen Hennig; Martin Buechert; Dominik von Elverfeldt
Journal: MAGMA Date: 2011-01-07 Impact factor: 2.310

Review 4. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors: Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal: Clin J Am Soc Nephrol Date: 2010-05-24 Impact factor: 8.237

5. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors: Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal: Mol Genet Metab Date: 2007-06-18 Impact factor: 4.797

Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

Review 1. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

2. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

3. Volumetric analysis of MRI data monitoring the treatment of polycystic kidney disease in a mouse model.

Review 4. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

5. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

6. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.

7. Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin treated mouse model of ADPKD.

8. TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum.

Review 9. Cystic kidney disease: the role of Wnt signaling.

Review 10. Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.